News Story
17 July 2019

NICE to consider lenalidomide maintenance treatment for myeloma patients post high dose therapy and stem cell transplantation

News Story
08 July 2019

Daratumumab combination treatment approved for use on the NHS in Scotland

Myeloma patients at first relapse in Scotland will now be able to access the new treatment of daratumumab (Darzalex®), bortezomib (Velcade®) and dexamethasone on the NHS after it was approved for use by the Scottish Medicines Consortium (SMC).

News Story
17 May 2019

Double approval from NICE increases NHS treatment options in England and Wales

The National Institute of Health and Care Excellence (NICE) has today approved the myeloma treatment lenalidomide (Revlimid®) and dexamethasone for use in treating newly diagnosed patients and patients at first relapse.

Featured News Story
12 March 2019

Daratumumab combination treatment approved for NHS use in England and Wales through the Cancer Drugs Fund

Myeloma patients at first relapse in England and Wales will now be able to access the new treatment of daratumumab (Darzalex®), bortezomib (Velcade®) and dexamethasone on the NHS after it was approved for use through the Cancer Drugs Fund (CDF).

Featured News Story
26 February 2019

NHS England’s 10 year plan: new ways to provide care ‘out-of-hospital’

The Myeloma UK Patient Advocacy team looks at ‘out-of-hospital’ care and its place at the heart of what NHS England's 10 year plan.

Featured News Story
31 January 2019

NHS England’s 10 year plan: detecting and diagnosing cancer more quickly

The Myeloma UK Patient Advocacy Team takes a look at the NHS England 10 year plan, and the implications it will have for myeloma patients.

Featured News Story
04 September 2018

Myeloma UK joins campaign putting the spotlight on blood cancers

Featured News Story
12 July 2018

NICE issues draft “no” on daratumumab combination

News Story
23 March 2018

Myeloma UK attends several conferences about blood cancers

News Story
20 March 2018

Myeloma UK signs letter to MPs about future of cancer research post-Brexit

News Story
06 December 2017

Myeloma UK Patient Information is awarded quality mark

News Story
28 November 2017

Myeloma Early Diagnosis Working Group have last meeting of 2017

News Story
30 October 2017

UK myeloma patients invited to test new quality of life questionnaire

News Story
04 October 2017

The Helplines Partnership reaccredits Myeloma UK services for the 13 year running

News Story
19 September 2017

Myeloma UK celebrates reaching 100 UK and Ireland Support Groups

Myeloma UK has celebrated a new milestone after reaching 100 Support Groups across the UK and Ireland.

News Story
15 September 2017

New report calls for wider inclusion in clinical trials

News Story
14 September 2017

Myeloma patient helps raise awareness in bespoke art installation

News Story
25 August 2017

Myeloma UK participates in first Oxford Myeloma Workshop

News Story
26 July 2017

UHNM joins Myeloma UK Clinical Trial Network

News Story
25 July 2017

First Myeloma UK Carer and Family Infoday hailed a success

Older posts